Aurora Cannabis IncACB
ASignal's systematic analysis rates ACB as Neutral.
Reflects the latest available analysis · analyzed Aug 20, 2026
The case on ACB
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong MACD momentum with histogram expansion
- Price above 20-day and 50-day moving averages
- Low debt-to-equity ratio (0.04x) indicating strong financial health
- High current ratio (5.36x) suggesting solid short-term liquidity
- RSI at 79.35 indicating overbought conditions
- Negative operating cash flow (-$28.08M)
- Negative free cash flow (-$20.04M)
- Negative net and operating margins
- Declining year-over-year revenue growth (-8.80%)
- Negative return on equity (-9.40%)
See the full verdict on ACB
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ACB
Most investors never get a second opinion, let alone several. ASignal runs ACB past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.